Bladder Neck Contracture (BNC)
Reconstruction of the bladder neck after endoscopic prostate surgery (TURP, HoLEP, ThuLEP, monopolar / bipolar resection). Incidence ~2–4.7%. Per AUA 2023, transurethral incision and bladder-neck resection have comparable outcomes, and repeat endoscopic treatment may be necessary. ≥ 2 prior failed endoscopic treatments is the strongest predictor of further endoscopic failure. Open Y-V plasty has reported 100% patency (Shamout 2022) but a high rate of persistent storage symptoms; staged AUS or sling after stable patency yields 91% patient satisfaction with continence (Brede 2014).
Success rates should be interpreted cautiously — definitions of success vary (patent lumen, continence, freedom from reintervention), follow-up intervals differ, and most data come from small case series.
Decision Framework
| Clinical Scenario | First-Line | Second-Line (if first fails) | Recalcitrant / Refractory |
|---|---|---|---|
| First-time post-TURP / endoscopic-BPH BNC | TUIBNC (Collins / cold knife at 3 & 9 o'clock) or BN resection | Repeat endoscopic ± mitomycin C; TUITMR (Abramowitz 2021) | Open / robotic Y-V plasty or T-plasty |
| Highly recurrent BNC (≥ 2 endoscopic failures, non-radiated) | Open or laparoscopic Y-V plasty (Shamout 2022; Zang 2022) | Primary re-anastomosis (open / robotic / transvesical) (Pfalzgraf 2011; TURNS 2018/2022; Lee/Eun 2025); robotic subtrigonal BMG inlay (Avallone 2019) | Urinary diversion |
| BNC + concurrent severe SUI | Stabilize patency endoscopically or surgically → delayed AUS or male sling (Brede 2014; ~91% satisfaction) | Reconstruction + delayed AUS | Urinary diversion |
| Orthotopic neobladder BNC | Endoscopic incision + 1-month CIC (58% vs 32% success with vs without; Pariser 2015) | Repeat endoscopic ± steroid injection | Continent catheterizable channel (Mitrofanoff); urinary diversion |
| Devastated bladder outlet (failed reconstruction; densely fibrotic) | Permanent suprapubic tube or chronic catheter drainage | Bladder-neck closure + continent catheterizable channel (Mitrofanoff) | Urinary diversion ± cystectomy (~5–8% of refractory BNC; Martins 2021) |
Treatment Database
14 of 14 techniques
| Technique | Tier | Success Rate | Best for / indication |
|---|---|---|---|
| Transurethral Incision of BNC (TUIBNC) | Endoscopic — First-Line | 82% (1×) / 94% (2×) | First-line treatment of BNC after endoscopic prostate surgery (TURP/HoLEP). |
| Transurethral Bladder Neck Resection (TURBN) | Endoscopic — First-Line | Comparable to incision | First-time BNC when surgeon prefers loop-electrode resection over cold-knife incision. |
| Balloon Dilation for BNC | Endoscopic — First-Line | ~59% standalone / 82–94% combined | Adjunct to incision/resection; standalone option when continence preservation is paramount. |
| Transurethral Incision with Transverse Mucosal Realignment (TUITMR) | Endoscopic — Adjunct / Novel | 89% (1×) / 100% (2×) | Recurrent BNC where mucosal coverage of the incision is desired without open reconstruction; useful in radiated patients. |
| Y-V Plasty (Robotic / Open) | Reconstruction — Robotic | 75–90.5% patency | Recalcitrant BNC after ≥2 failed endoscopic treatments; non-radiated patients with stenosis ≤2 cm. |
| Robotic Subtrigonal BMG Inlay | Reconstruction — Robotic | Promising early data | Refractory BNC where mucosal augmentation is preferred over excision/anastomosis. |
| Robotic Bladder Flap Posterior Urethroplasty | Reconstruction — Robotic | 78% (7/9) at 21 wk | Recalcitrant BNC where the bladder neck must be transected and dystrophic tissue excised, with VUA reconstructed from an anterior bladder-wall flap. |
| Transvesical RARP for Recalcitrant BNC | Reconstruction — Robotic | 100% at ≥6 mo | Recalcitrant post-HoLEP BNC where residual prostate tissue is the source of recurrent contracture. |
| T-Plasty | Reconstruction — Open | 100% at 45 mo | Highly recurrent post-TURP/BPH BNC at centers without robotic platform; longest-follow-up open option. |
| Tanagho Flap | Reconstruction — Open | — | Female urethral reconstruction with total urethral loss; complex incontinence unsuitable for AUS. |
| Bladder Neck Closure | Continence-Creating Outlet | Definitive | Devastated or irreparably incontinent bladder neck; paired with a continent catheterizable channel. |
| Permanent Suprapubic Catheter | Salvage / Diversion | Temporizing or definitive | Devastated bladder outlet in non-reconstruction candidates; bridge or definitive drainage. |
| Continent Catheterizable Channel (Mitrofanoff) | Salvage / Diversion | Salvage / definitive | Continent abdominal-stoma alternative to permanent SPT after failed outlet reconstruction. |
| Urinary Diversion ± Cystectomy | Salvage / Diversion | ~5–8% of refractory BNC | Last resort for failed reconstruction in radiated, fibrotic, or comorbid patients. |